APA (7th ed.) Citation

CA, W., C, E., D, M., L, M., SB, H., E, K., . . . JS, L. (2024). Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer. Gynecologic oncology, 188, 22. https://doi.org/10.1016/j.ygyno.2024.05.028

Chicago Style (17th ed.) Citation

CA, Walker, Edwards C, McIntire D, Makepeace L, Holloway SB, Kakadiaris E, Spirtos AN, Miller DS, and Lea JS. "Predicting VTE and Utility of Thromboprophylaxis in Metastatic and Recurrent Cervical Cancer." Gynecologic Oncology 188 (2024): 22. https://doi.org/10.1016/j.ygyno.2024.05.028.

MLA (9th ed.) Citation

CA, Walker, et al. "Predicting VTE and Utility of Thromboprophylaxis in Metastatic and Recurrent Cervical Cancer." Gynecologic Oncology, vol. 188, 2024, p. 22, https://doi.org/10.1016/j.ygyno.2024.05.028.